the molecular and clinical classifications of mds
Published 2 years ago • 114 plays • Length 5:38Download video MP4
Download video MP3
Similar videos
-
4:42
a practical approach to the classification of mds
-
10:18
classification of high-risk mutations in mds
-
2:03
molecular pathogenesis and immune dysregulation in mds
-
1:57
combining molecular and clinical data to predict survival & transformation risk in patients with mds
-
3:31
relevance of the ipss-r during sct in patients with mds in the molecular classification era
-
7:54
patient/caregiver stories - living with mds
-
4:32
recent advances in the treatment of lr-mds: commands and imerge trial data
-
4:28
understanding myelodysplastic syndromes (mds)
-
3:11
clinical characteristics of h-mds
-
1:41
an overview of the mds diagnosis pathway
-
2:03
challenges with mds classification: morphological characterization and molecular testing
-
2:47
molecular background studies to aid diagnosis and treatment of mds
-
5:14
prognostic value of the updated icc and who classifications for mds
-
6:48
classification and characteristics of mds
-
1:40
mds 2023 highlights: classification and risk stratification systems & progression from ch to mds
-
3:56
the genetic landscape of mds and impact on treatment
-
3:01
the role of piez01 variants in patients with mds
-
1:59
mds pathology and comorbidities
-
1:17
phase ii study of tosedostat in mds
-
1:16
state of the art: mds
-
1:32
the role of the innate immune system in mds pathogenesis
-
3:17
pre-mds states: novel therapeutic approaches, and determining appropriate trial endpoints